-
1
-
-
33847650869
-
Overview: Helicobacter pylori and extragastric disease
-
Suzuki H, Marshall BJ, Hibi T. Overview: Helicobacter pylori and extragastric disease. Int J Hematol 2006; 84: 291-300.
-
(2006)
Int J Hematol
, vol.84
, pp. 291-300
-
-
Suzuki, H.1
Marshall, B.J.2
Hibi, T.3
-
2
-
-
33847660516
-
Helicobacter pylori: Present status and future prospects in Japan
-
Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: Present status and future prospects in Japan. J Gastroenterol 2007; 42: 1-15.
-
(2007)
J Gastroenterol
, vol.42
, pp. 1-15
-
-
Suzuki, H.1
Hibi, T.2
Marshall, B.J.3
-
3
-
-
0025331686
-
Cure of duodenal ulcer associated with eradication of Helicobacter pylori
-
Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233-5.
-
(1990)
Lancet
, vol.335
, pp. 1233-1235
-
-
Rauws, E.A.1
Tytgat, G.N.2
-
4
-
-
0034855743
-
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients
-
Asaka M, Sugiyama T, Kato M et al. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter 2001; 6: 254-61.
-
(2001)
Helicobacter
, vol.6
, pp. 254-261
-
-
Asaka, M.1
Sugiyama, T.2
Kato, M.3
-
5
-
-
0033983566
-
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan
-
Hoshiya S, Watanabe K, Tokunaga K et al. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. J Gastroenterol 2000; 35: 10-4.
-
(2000)
J Gastroenterol
, vol.35
, pp. 10-14
-
-
Hoshiya, S.1
Watanabe, K.2
Tokunaga, K.3
-
6
-
-
18644362493
-
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin
-
Murakami K, Sato R, Okimoto T et al. Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. Aliment Pharmacol Ther 2002; 16: 1933-8.
-
(2002)
Aliment Pharmacol Ther
, vol.16
, pp. 1933-1938
-
-
Murakami, K.1
Sato, R.2
Okimoto, T.3
-
7
-
-
18644378213
-
The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance
-
Perez Aldana L, Kato M, Nakagawa S. et al. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 2002; 7: 306-9.
-
(2002)
Helicobacter
, vol.7
, pp. 306-309
-
-
Perez Aldana, L.1
Kato, M.2
Nakagawa, S.3
-
8
-
-
1842508149
-
Characteristics and trends of clarithromycin-resistant Helicobacter pylori isolates in Japan over a decade
-
Masuda H, Hiyama T, Yoshihara M et al. Characteristics and trends of clarithromycin-resistant Helicobacter pylori isolates in Japan over a decade. Pathobiology 2004; 71: 159-63.
-
(2004)
Pathobiology
, vol.71
, pp. 159-163
-
-
Masuda, H.1
Hiyama, T.2
Yoshihara, M.3
-
9
-
-
0029903276
-
In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori
-
Koga T, Kawada H, Utsui Y et al. In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori. J Antimicrob Chemother 1996; 37 919-29.
-
(1996)
J Antimicrob Chemother
, vol.37
, pp. 919-929
-
-
Koga, T.1
Kawada, H.2
Utsui, Y.3
-
10
-
-
0035996118
-
Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo
-
Koga T, Inoue H, Ishii C et al. Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo. J Antimicrob Chemother 2002; 50: 133-6.
-
(2002)
J Antimicrob Chemother
, vol.50
, pp. 133-136
-
-
Koga, T.1
Inoue, H.2
Ishii, C.3
-
12
-
-
0013575179
-
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994
-
Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
-
(1996)
Am J Surg Pathol
, vol.20
, pp. 1161-1181
-
-
Dixon, M.F.1
Genta, R.M.2
Yardley, J.H.3
-
13
-
-
32944475349
-
Suppressive effects of fruit-juice concentrate of Prunus mume Sieb. et Zucc. (Japanese apricot, Ume) on Helicobacter pylori-induced glandular stomach lesions in Mongolian gerbils
-
Otsuka T, Tsukamoto T, Tanaka H et al. Suppressive effects of fruit-juice concentrate of Prunus mume Sieb. et Zucc. (Japanese apricot, Ume) on Helicobacter pylori-induced glandular stomach lesions in Mongolian gerbils. Asian Pac J Cancer Prev 2005; 6 337-41.
-
(2005)
Asian Pac J Cancer Prev
, vol.6
, pp. 337-341
-
-
Otsuka, T.1
Tsukamoto, T.2
Tanaka, H.3
-
14
-
-
4344591515
-
Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis
-
Masaoka T, SuzukiKurabayeshi HK, Kamiya AG et al. Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis. Aliment Pharmacol Ther 2004; 20 Suppl 1: 68-73.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, Issue.SUPPL. 1
, pp. 68-73
-
-
Masaoka, T.1
SuzukiKurabayeshi, H.K.2
Kamiya, A.G.3
-
15
-
-
0031873739
-
Interactions of plaunotol with bacterial membranes
-
Koga T, Watanabe H, Kawada H et al. Interactions of plaunotol with bacterial membranes. J Antimicrob Chemother 1998; 42: 133-40.
-
(1998)
J Antimicrob Chemother
, vol.42
, pp. 133-140
-
-
Koga, T.1
Watanabe, H.2
Kawada, H.3
-
16
-
-
0029120666
-
Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori
-
Fukuda Y, Yamamoto I, Okui M et al. Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7 Suppl 1: S45-7.
-
(1995)
Eur J Gastroenterol Hepatol
, vol.7
, Issue.SUPPL. 1
-
-
Fukuda, Y.1
Yamamoto, I.2
Okui, M.3
-
17
-
-
33645768501
-
Gatifloxacin resistance and mutations in gyrA after unsuccessful Helicobacter pylori eradication in Japan
-
Nishizawa T, Suzuki H, Kurabayashi K et al. Gatifloxacin resistance and mutations in gyrA after unsuccessful Helicobacter pylori eradication in Japan. Antimicrob Agents Chemother 2006; 50: 1538-40.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 1538-1540
-
-
Nishizawa, T.1
Suzuki, H.2
Kurabayashi, K.3
|